Results 21 to 30 of about 588,627 (186)

Evaluation of mean platelet volume in localized scleroderma [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Background: Localized scleroderma is a chronic inflammatory skin disease characterized by sclerosis of the dermis and subcutaneous tissue. Platelets play an important role in inflammation.
Anil Gulsel Bahali   +5 more
doaj   +2 more sources

Localized Scleroderma: A Clinical Review

open access: yesCurrent Rheumatology Reviews, 2017
Localized scleroderma (LS) is characterized by excessive collagen deposition leading to thickening of the dermis, subcutaneous tissue or both. The outcome for most patients with localized scleroderma is directly related to the type and stage of the affected tissue.
Mark, Tratenberg   +5 more
openaire   +3 more sources

Synthetic Nucleic Acid Antigens in Localized Scleroderma. [PDF]

open access: yesInt J Mol Sci, 2023
We investigated the impact of synthetic nucleic acid antigens on the autoantibody profiles in patients with localized scleroderma, an autoimmune skin disease. Anti-DNA antibodies, including double-stranded DNA (dsDNA) and single-stranded DNA (ssDNA), are
Khatri S   +5 more
europepmc   +2 more sources

A Patient with Localized Scleroderma Successfully Treated with Etretinate

open access: yesCase Reports in Dermatology, 2014
There are several treatment methods for localized scleroderma, but treatment is difficult when the lesion is widely distributed. We encountered a case who was treated successfully with etretinate, a vitamin A derivative.
Tomoko Shima   +3 more
doaj   +2 more sources

Parry-Romberg Syndrome Associated with Localized Scleroderma

open access: yesCase Reports in Neurology, 2010
Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is characterized by progressive facial hemiatrophy and frequently overlaps with a condition known as linear scleroderma ‘en coup de sabre’.
Jelena Maletic   +4 more
doaj   +2 more sources

A case of localized bullous scleroderma

open access: yesVestnik Dermatologii i Venerologii, 2017
Bullous scleroderma is a rare type of the focal form of the disease mainly affecting the skin and characterized by induration and sclerosis foci as well as subepidermal blisters containing a transparent matter.
A. L. Bakulev   +3 more
doaj   +2 more sources

Localized scleroderma in a 12-year-old girl presenting as gingival recession. A case report and literature review.

open access: yes, 2001
Scleroderma is a connective tissue disorder that displays considerable clinical heterogeneity. This case describes a 12-year-old girl who presented with a localized form of the disease.
Shaw, L.   +3 more
core   +12 more sources

Targeting Ero1L by Parthenolide Alleviates Cellular Senescence and Fibrosis of Localized Scleroderma by Regulating Mitochondria-Associated Endoplasmic Reticulum Membranes Stabilization. [PDF]

open access: yesAging Cell
PTL inhibits cell senescence and alleviates fibrosis of Los by regulating Ero1L‐mediated mitochondria‐associated endoplasmic reticulum membranes stabilization. ABSTRACT Mitochondrial dysfunction drives scleroderma pathogenesis. The mitochondria‐associated endoplasmic reticulum membrane (MAM) regulates mitochondrial function.
Wang F   +7 more
europepmc   +2 more sources

Immunopathogenesis of Pediatric Localized Scleroderma [PDF]

open access: yesFrontiers in Immunology, 2019
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibrosis of the skin that, especially in the pediatric population, also affects extracutaneous tissues ranging from muscle to the central nervous system ...
Kathryn S. Torok   +11 more
doaj   +3 more sources

Janus kinase inhibitors in localized scleroderma: a systematic literature review. [PDF]

open access: yesTurk J Med Sci
BACKGROUND/AIM: Reports on the use of Janus kinase (JAK) inhibitors in the treatment of localized scleroderma are increasing in the literature. In this review, we examined the published studies regarding the use of JAK inhibitors in patients with ...
Şener S   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy